Can a pandemic flu shot protect vulnerable transplant patients?
NCT ID NCT07240558
First seen Nov 21, 2025 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests a two-dose pandemic H5N1 (bird flu) vaccine in 120 organ transplant recipients. The goal is to see if the vaccine is safe and helps their immune system fight the flu. Participants must be at least 18 years old, more than 3 months post-transplant, and have stable kidney function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health Network
RECRUITINGToronto, Ontario, M5G2N2, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.